13F-HR filed by Sio Capital Management, LLC
Sio Capital Management, LLC filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-14, with 76 holding rows worth $697,308,424.
- Accession
- 0001214659-26-006200
- Filer
- CIK 1482416
- Filed
- 2026-05-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 76 entries on the cover page, a total value of $697,308,424 stated on the cover page (in dollars after the unit check, H1), rows summing to $697,308,424 with VALUE read as dollars as filed, 13F file number 028-13691. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MAXIMUS INC | 577933104 | COM | 768,825 | $49,281,683 | dollars as filed | |
| WAYSTAR HLDG CORP | 946784105 | COM | 1,642,236 | $39,594,310 | dollars as filed | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 306,358 | $33,901,576 | dollars as filed | |
| CENCORA INC COM | 03073E105 | Stock | 100,894 | $31,694,841 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 370,045 | $31,054,176 | dollars as filed | |
| ANTERIS TECHNOLOGIES GLOBAL | 03675P102 | COMMON STOCK | 5,382,965 | $29,875,456 | dollars as filed | |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 674,759 | $27,199,535 | dollars as filed | |
| LIVANOVA PLC | G5509L101 | SHS | 421,615 | $26,797,849 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 605,439 | $23,188,314 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 193,843 | $22,125,240 | dollars as filed | |
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 385,879 | $21,296,662 | dollars as filed | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 265,543 | $20,420,257 | dollars as filed | |
| Abbott Laboratories | 002824100 | COM | 186,574 | $19,155,553 | dollars as filed | |
| EMBECTA CORP | 29082K105 | COMMON STOCK | 1,847,850 | $16,334,994 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 135,800 | $15,121,330 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 1,498,620 | $13,427,635 | dollars as filed | |
| HAEMONETICS CORP MASS COM | 405024100 | Stock | 220,672 | $12,437,074 | dollars as filed | |
| SIONNA THERAPEUTICS INC | 829401108 | COMMON STOCK | 294,340 | $11,800,091 | dollars as filed | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 239,671 | $11,547,349 | dollars as filed | |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 366,809 | $11,477,454 | dollars as filed | |
| TELEFLEX INCORPORATED | 879369106 | COM | 94,800 | $11,339,028 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 194,226 | $10,971,827 | dollars as filed | |
| CROSS CTRY HEALTHCARE INC | 227483104 | COM | 1,098,393 | $10,324,894 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 1,969,839 | $10,262,861 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 209,093 | $10,078,283 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 1,163,926 | $9,846,814 | dollars as filed | |
| MONOPAR THERAPEUTICS INC | 61023L207 | COMMON STOCK | 173,506 | $9,506,394 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 721,785 | $9,303,809 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 249,887 | $9,075,896 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 268,986 | $8,473,059 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 1,506,525 | $8,331,083 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 968,597 | $8,204,017 | dollars as filed | |
| AQUESTIVE THERAPEUTICS INC COM | 03843E104 | Stock | 1,922,887 | $7,979,981 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 965,000 | $6,716,400 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 132,496 | $6,498,929 | dollars as filed | |
| ZENAS BIOPHARMA INC COM | 98937L105 | Stock | 331,730 | $6,485,322 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 86,083 | $6,281,477 | dollars as filed | |
| QUIDELORTHO CORP COM | 219798105 | Stock | 359,011 | $5,898,551 | dollars as filed | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 62,613 | $5,661,467 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 720,036 | $5,508,275 | dollars as filed | |
| ORGANON & CO COMMON STOCK | 68622V106 | Stock | 865,908 | $5,186,789 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 1,078,965 | $4,466,915 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 65,203 | $4,169,080 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 3,076,580 | $3,814,959 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 165,110 | $3,610,956 | dollars as filed | |
| INTEGRA LIFESCIENCES HLDGS C | 457985208 | COM NEW | 383,140 | $3,609,179 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 613,888 | $3,351,828 | dollars as filed | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 100,000 | $3,274,000 | dollars as filed | put |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 1,954,715 | $3,166,638 | dollars as filed | |
| SHOULDER INNOVATIONS INC | 82537J108 | COMMON STOCK | 210,641 | $3,060,614 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 1,252,381 | $2,780,286 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 32,235 | $2,684,853 | dollars as filed | |
| ALIGOS THERAPEUTICS INC | 01626L204 | COM NEW | 327,237 | $2,431,371 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 917,922 | $2,404,956 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 657,200 | $2,247,624 | dollars as filed | |
| SERINA THERAPEUTICS INC | 81751A108 | COM SHS | 1,000,000 | $1,940,000 | dollars as filed | |
| IBIO INC | 451033708 | CMN | 904,268 | $1,718,109 | dollars as filed | |
| Adagio Med Hldgs Inc Com | 00534B100 | Common Stock | 1,288,461 | $1,481,730 | dollars as filed | |
| XILIO THERAPEUTICS INC | 98422T209 | COM | 152,464 | $1,282,222 | dollars as filed | |
| BRIDGEBIO ONCOLOGY THERAPEUT | 107924102 | COM NEW | 130,628 | $1,169,121 | dollars as filed | |
| HYPERFINE INC | 44916K106 | Common Stock | 1,000,000 | $1,080,000 | dollars as filed | |
| SENSEONICS HOLDINGS INC | 81727U303 | COMMON STOCK | 115,784 | $771,121 | dollars as filed | |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 122,889 | $587,409 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 10,100 | $532,472 | dollars as filed | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 40,000 | $505,200 | dollars as filed | |
| TELA BIO INC | 872381108 | COM | 636,300 | $394,506 | dollars as filed | |
| NEUROONE MED TECHNOLOGIES CORP COM | 64130M209 | Stock | 496,614 | $385,621 | dollars as filed | |
| BOUNDLESS BIO INC | 10170A100 | COM | 163,679 | $180,047 | dollars as filed | |
| NYXOAH S A | B6S7WD106 | SHS | 50,839 | $148,450 | dollars as filed | |
| Modular Medical, Inc. | 60785L306 | COM | 26,190 | $138,283 | dollars as filed | |
| Elicio Therapeutics Inc Com | 28657F103 | LST Equity Option | 11,700 | $125,073 | dollars as filed | put |
| ERASCA INC COM | 29479A108 | Stock | 5,000 | $80,900 | dollars as filed | |
| OSCAR HEALTH INC | 687793109 | CL A | 3,000 | $34,410 | dollars as filed | put |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 400,000 | $7,020 | dollars as filed | |
| Humacyte Inc W Exp 08/27/202 | 44486Q111 | SPAC Combination | 49,998 | $4,572 | dollars as filed | |
| SIMULATIONS PLUS INC | 829214105 | COM | 200 | $2,364 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-26-006200 | this filing | 2026-05-14 | acceptance time not in the bulk data set |